CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
Cyclin dependent kinase 11 (CDK11) is a protein kinase that regulates RNA transcription, pre-mRNA splicing, mitosis, and cell death. Targeting of CDK11 expression levels is effective in the experimental treatment of breast and other cancers, but these data are lacking in melanoma. To understand CDK1...
Main Authors: | Rehana L. Ahmed, Daniel P. Shaughnessy, Todd P. Knutson, Rachel I. Vogel, Khalil Ahmed, Betsy T. Kren, Janeen H. Trembley |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/12/2/50 |
Similar Items
-
Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management
by: Liang XR, et al.
Published: (2023-07-01) -
The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers
by: Ayat Lashen, et al.
Published: (2024-04-01) -
CDK Regulation of Meiosis: Lessons from <i>S. cerevisiae</i> and <i>S. pombe</i>
by: Anne M. MacKenzie, et al.
Published: (2020-06-01) -
Mouse Model of Congenital Heart Defects, Dysmorphic Facial Features and Intellectual Developmental Disorders as a Result of Non-functional CDK13
by: Monika Nováková, et al.
Published: (2019-08-01) -
Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells
by: Tomáš Kyca, et al.
Published: (2021-05-01)